Wordt geladen...
Therapeutic Advances in Oncology
Around 77 new oncology drugs were approved by the FDA in the past five years; however, most cancers remain untreated. Small molecules and antibodies are dominant therapeutic modalities in oncology. Antibody-drug conjugates, bispecific antibodies, peptides, cell, and gene-therapies are emerging to ad...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922397/ https://ncbi.nlm.nih.gov/pubmed/33670524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22042008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|